Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016

Autor: Avinash G. Dinmohamed, Hidde L. A. Posthuma, Marie José Kersten, Pieternella J. Lugtenburg, Josée M. Zijlstra, Otto Visser
Přispěvatelé: Hematology, Public Health, CCA - Cancer Treatment and quality of life, CCA - Cancer Treatment and Quality of Life, Clinical Haematology
Rok vydání: 2019
Předmět:
Adult
Male
medicine.medical_specialty
Population
Short Report
Disease
Population based
population‐based registry
survival
Disease-Free Survival
Primary therapy
03 medical and health sciences
0302 clinical medicine
Short Reports
Risk Factors
Internal medicine
Epidemiology of cancer
medicine
Humans
Young adult
education
Aged
Netherlands
Retrospective Studies
Aged
80 and over
education.field_of_study
business.industry
Incidence (epidemiology)
Age Factors
Haematological Malignancy ‐ Clinical
Hematology
Middle Aged
Hodgkin Disease
nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)
Survival Rate
Nodular Lymphocyte Predominant Hodgkin Lymphoma
030220 oncology & carcinogenesis
incidence
Female
population-based registry
business
nodular lymphocyte‐predominant Hodgkin lymphoma (NLPHL)
cancer epidemiology
030215 immunology
Zdroj: British Journal of Haematology, 189(1), 117-121. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 189(1), 117-121. Wiley-Blackwell
British journal of haematology, 189(1), 117-121. Wiley-Blackwell
British Journal of Haematology
Posthuma, H L A, Zijlstra, J M, Visser, O, Lugtenburg, P J, Kersten, M J & Dinmohamed, A G 2020, ' Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma : a population-based analysis in the Netherlands, 1993–2016 ', British Journal of Haematology, vol. 189, no. 1, pp. 117-121 . https://doi.org/10.1111/bjh.16290
ISSN: 1365-2141
0007-1048
DOI: 10.1111/bjh.16290
Popis: Summary In this nationwide, population‐based study, we assessed trends in primary treatment and survival among 687 patients with nodular lymphocyte‐predominant Hodgkin lymphoma (75% males; median age, 40 years; and 74% stage‐I/II disease) diagnosed in the Netherlands between 1993–2016. There were no noteworthy changes in the application of primary therapy over time among adult patients across the different disease stages and age groups. Survival among various subgroups of adult patients was largely comparable to the expected survival of the general population. A particularly encouraging finding was that young adult patients experienced virtually no excess mortality, as compared to the general population.
Databáze: OpenAIRE
Externí odkaz: